1 |
Yamana H, Imai S, Yamasaki K, Horiguchi H, Ario K, Komatsu T, Sugimoto R, Katsushima S, Naganuma A, Mano Y, Yamashita T, Kamitsukasa H, Tsuruta S, Jo T, Yasunaga H, Fushimi K, Yatsuhashi H. Prognosis of patients with liver cirrhosis: A multi-center retrospective observational study. Hepatol Res 2021. [PMID: 34492143 DOI: 10.1111/hepr.13711] [Reference Citation Analysis]
|
3 |
Atsukawa M, Tsubota A, Kondo C, Toyoda H, Nakamuta M, Takaguchi K, Watanabe T, Hiraoka A, Uojima H, Ishikawa T, Iwasa M, Tada T, Nozaki A, Chuma M, Fukunishi S, Asano T, Ogawa C, Abe H, Kato K, Hotta N, Shima T, Matsuura K, Mikami S, Tachi Y, Fujioka S, Okubo H, Shimada N, Tani J, Morishita A, Hidaka I, Moriya A, Tsuji K, Akahane T, Okubo T, Arai T, Kitamura M, Morita K, Kawata K, Tanaka Y, Kumada T, Iwakiri K; KTK49 Liver Study Group. Time-course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis. Hepatol Res 2021. [PMID: 34861090 DOI: 10.1111/hepr.13739] [Reference Citation Analysis]
|